---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-038690"
form_type: "8-K"
ticker: "ATRA"
cik: "0001604464"
company_name: "Atara Biotherapeutics, Inc."
filed_at: "2024-03-29T23:59:59+00:00"
generated_at: "2026-06-04T05:21:59.522833+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Eric Dobmeier to not stand for re-election at Atara's 2024 annual meeting

## Summary
- Eric Dobmeier notified Atara on March 26, 2024, he will not stand for re-election at the 2024 annual meeting.
- He will continue as director until his term expires at the 2024 Annual Meeting.
- No disagreement with Board or management; decision not related to operations, policies, or practices.

## SEC filing metadata
- accession: 0000950170-24-038690
- form_type: 8-K
- ticker: ATRA
- cik: 0001604464
- company_name: Atara Biotherapeutics, Inc.
- filed_at: 2024-03-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604464/000095017024038690/0000950170-24-038690-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604464/000095017024038690/atra-20240326.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-038690
- JSON: https://secwatch.observer/filing/0000950170-24-038690.json
- Plain text: https://secwatch.observer/filing/0000950170-24-038690.txt

## Key facts
- Executive change
  Eric Dobmeier departed as Director at Atara Biotherapeutics, Inc..
  - Action: not stand for re-election
  - Role: Director
  source text: On March 26, 2024, Eric Dobmeier, a member of the Board of Directors (the “Board”) of Atara Biotherapeutics, Inc., a Delaware corporation (the “Company”), notified the Company of his decision to not stand for re-election to the Board at the Company’s 2024 annual meeting of stockholders (“2024 Annual Meeting”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1604464/000095017024038690/0000950170-24-038690-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.